Shilpa Medicare has launched Prucalshil (prucalopride) orally disintegrating strips 1 mg and 2 mg' in India, a unique formulation, which the company said was developed for the first time. The company has developed a novel 'Orally Disintegrating Strip (ODS)' formulation for prucalopride and obtained subsequent approval from Drug Control General of India.

Prucalopride is used for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief.

Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients. Orally Disintegrating Strips have an advantage such as greater dissolution due to large surface area, more patient compliance than oral tablets, no risk of choking & better taste masking etc.

Orally Disintegrating Strips technology is emerging in novel drug delivery formulations. The company has acquired expertise with compliance-oriented research for development of novel and safer drug delivery such as oral strips keeping in mind patient convenience.

Prucalshil launch will help build company's gastro portfolio.